Study Details

Back
Study ID 1585-CL-0002
Study Title A Phase 2, Dose-ranging Study for ASP1585 in Patients With Chronic Kidney Disease(CKD) and Hyperphosphatemia on Hemodialysis(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT00505037
Compound Name ASP1585 / bixalomer
Medical Indication or Disease Hyperphosphatemia
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 01-Oct-2007
Study Completion Date 27-May-2008
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS